Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-10-10
2006-10-10
Campbell, Bruce R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S017400, C530S331000, C530S330000, C530S329000
Reexamination Certificate
active
07119073
ABSTRACT:
Compounds of formula (I), and pharmaceutically acceptable salts and esters thereof: (I); wherein Q, R2, X, Y and Z are as defined herein; are inhibitors of the hepatitis C virus (HCV) NS3 protease
REFERENCES:
patent: 4297346 (1981-10-01), Rips et al.
patent: WO 9206108 (1992-04-01), None
patent: WO 98/46630 (1998-10-01), None
patent: WO 99/64442 (1999-12-01), None
Llinas-Brunet, M. et al., “Peptide-Based Inhibitors of the Hepatitis C Virus Serine Protease”, 1998, Bioorganic & Medicinal Chemistry Letters, vol. 8, No. 13, pp. 1713-17318.
Bailey, M.D. et al., “Novel C-Terminal Carboxylic Acid Tri-Peptide Inhibitors of Hepatitis C Virus Serine Protease”, American Chemical Society, vol. 220, pp. MED188 XP00964834 (2000).
Landro, J.A. et al., “Mechanistic Role of an NS4A Peptide Cofactor with the Truncated NS3 Protease of Hepatitis C Virus: Elucidation of the NS4A Stimulatory Effect via Kinetic Analysis and Inhibitor Mapping”, 1997, Biochemistry, vol. 35, No. 11, pp. 9340-9348.
Llinas-Brunet M. et al., “Studies on the C-Terminal of Hexapeptide Inhibitors of the Hepatitis C Virus Serine Protease”, 1998, Biorganic Medicinal Chemistry Letters 8, pp. 2719-2724.
Beilstein Registry No. 8123814, XP-002206365, reference to: Eaton S.R., et al., J. Med. Chem., 1998, vol. 41, No. 22, pp. 4329-4342.
Beilstein Registry No. 5835997, XP002206366, reference to: Rich, D.H., et al., J. Med. Chem., 1992, vol. 35, No. 21, pp. 3803-3812.
Colarusso Stefania
Gardelli Cristina
Gerlach Benjamin
Harper Steven
Koch Uwe
Camara Valerie J.
Campbell Bruce R.
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti SpA
Kosar Andrew D.
Walton Kenneth R.
LandOfFree
Peptides and their use as inhibitors of hepatitis C virus... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides and their use as inhibitors of hepatitis C virus..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides and their use as inhibitors of hepatitis C virus... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3631170